J 2021

Synthesis and Critical View on the Structure-Activity Relationships of N-(Substituted phenyl)-/N-Diphenylmethyl-piperazine-Based Conjugates as Antimycobacterial Agents

CURILLOVA, Jana, Maria PECHACOVA, Tereza PADRTOVÁ, Daniel PECHER, Sarka MASCARETTI et. al.

Základní údaje

Originální název

Synthesis and Critical View on the Structure-Activity Relationships of N-(Substituted phenyl)-/N-Diphenylmethyl-piperazine-Based Conjugates as Antimycobacterial Agents

Autoři

CURILLOVA, Jana (703 Slovensko), Maria PECHACOVA (703 Slovensko), Tereza PADRTOVÁ (203 Česká republika, domácí), Daniel PECHER (703 Slovensko), Sarka MASCARETTI (203 Česká republika), Josef JAMPÍLEK (203 Česká republika), Ludmila PASKOVA (703 Slovensko), Frantisek BILKA (703 Slovensko), Gustav KOVAC (703 Slovensko) a Ivan MALIK (703 Slovensko, garant)

Vydání

Applied sciences, Basel, MDPI, 2021, 2076-3417

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30107 Medicinal chemistry

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.838

Kód RIV

RIV/00216224:14160/21:00124261

Organizační jednotka

Farmaceutická fakulta

UT WoS

000752599900001

Klíčová slova anglicky

drug development; N-arylpiperazines; mycobacteria; electronic properties; lipophilicity; cytotoxicity; structure-activity

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 16. 3. 2022 13:39, PharmDr. Tereza Padrtová, Ph.D.

Anotace

V originále

This research focused on a three-step synthesis, analytical, physicochemical, and biological evaluation of hybrid molecules 6a-g, containing a lipophilic 3-trifluoromethylphenyl moiety, polar carbamoyloxy bridge, 2-hydroxypropan-1,3-diyl chain and 4-(substituted phenyl)-/4-diphenylmethylpiperazin-1-ium-1-yl fragment. The estimation of analytical and physicochemical descriptors (m/z(measured) via HPLC-UV/HR-MS, log epsilon(2 (Ch-T)) from UV/Vis spectrophotometry and log k(w) via RP-HPLC) as well as in vitro antimycobacterial and cytotoxic screening of given compounds were carried out (i.e., determination of MIC and IC50 values). These highly lipophilic molecules (log k(w) = 4.1170-5.2184) were tested against Mycobacterium tuberculosis H37Ra ATCC 25177 (Mtb H37Ra), M. kansasii DSM 44162 (MK), M. smegmatis ATCC 700084 (MS), and M. marinum CAMP 5644 (MM). The impact of the 6a-g set on the viability of human liver hepatocellular carcinoma (HepG2) cells was also investigated. 1-[2-Hydroxypropyl-{(3-trifluoromethyl)- phenyl}carbamoyloxy]-4-(3,4-dichlorophenyl)piperazin-1-ium chloride (6e) and 1-[2-hydroxy- propyl-{(3-trifluoromethyl)phenyl}carbamoyloxy]-4-(4-diphenylmethyl)piperazin-1-ium chloride (6g) most effectively inhibited the growth of Mtb H37Ra (MIC < 3.80 mu M). The substance 6g also showed interesting activity against MM (MIC = 8.09 mu M). All obtained data served as input values for structure-activity relationship evaluations using statistical principal component analysis. In fact, the toxicity of both 6e (IC50 = 29.39 mu M) and 6g (IC50 = 22.18 mu M) in HepG2 cells as well as selectivity index (SI) values (SI < 10.00) prevented to consider these promising antimycobacterials safe.